Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) caters to the Healthcare space. Its weekly performance is -3.72%. On the last day of trading company shares ended up at $2.07. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is 2.34%.
On 30 November, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for an extended release formulation of lorcaserin. If approved, the extended release formulation will offer patients a chronic weight management treatment in a once-daily dosing option.
Hercules Offshore, Inc. (NASDAQ:HERO) ended the last trading day at $3.03. Company weekly volatility is calculated as 10.33% and price to cash ratio as 3.87. Hercules Offshore, Inc. (NASDAQ:HERO) showed a weekly performance of -25.00%.
Hercules Offshore, Inc. (NASDAQ:HERO) announced that it has published a Fleet Status Report (“the Report”). The Report includes the Hercules Offshore Rig Fleet Status (as of November 24, 2015), which contains detailed contract information for each of the Company’s drilling rigs.
On 04 December, Central Valley Community Bancorp (NASDAQ:CVCY) shares advanced 4.20% and was closed at $11.67. CVCY EPS growth in last 5 year was 11.40%. Central Valley Community Bancorp (NASDAQ:CVCY) year to date (YTD) performance is 5.32%.
Zacks Investment Research upgraded shares of from a hold rating to a buy rating in a research report published on Thursday, Analyst Ratings Net reports. Zacks Investment Research currently has $12.00 price target on the financial services provider’s stock.
Morgan Stanley (NYSE:MS) shares advanced 2.53% in last trading session and ended the day at $35.32. MS Gross Margin is 86.90% and its has a return on assets of 0.40%. Morgan Stanley (NYSE:MS) quarterly performance is 6.92%.
Morgan Stanley (NYSE:MS) said that, it began cutting its fixed-income business in London and may continue reductions on Monday as it pares back global operations, according to people familiar with the matter.
Incyte Corporation (NASDAQ:INCY) caters to the Healthcare space. It has a net profit margin of -13.50% and weekly performance is -6.54%. On the last day of trading company shares ended up at $109.11. Incyte Corporation (NASDAQ:INCY) distance from 50-day simple moving average (SMA50) is 3.98%.
Incyte Corporation (NASDAQ:INCY) announced that more than 60 abstracts featuring data from its ongoing clinical development program for Jakafi® (ruxolitinib) will be presented at the upcoming American Society of Hematology (ASH) 57th Annual Meeting December 5-8, 2015 in Orlando, FL.
Leave a Reply